- Home
- ORGO vs NDMO Comparison
ORGO vs NDMO Comparison
Compare ORGO & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- NDMO
- Stock Information
- Founded
- ORGO 1985
- NDMO 2019
- Country
- ORGO United States
- NDMO United States
- Employees
- ORGO N/A
- NDMO N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- ORGO Health Care
- NDMO Finance
- Exchange
- ORGO Nasdaq
- NDMO Nasdaq
- Market Cap
- ORGO 539.1M
- NDMO 622.4M
- IPO Year
- ORGO N/A
- NDMO N/A
- Fundamental
- Price
- ORGO $5.14
- NDMO $10.57
- Analyst Decision
- ORGO Buy
- NDMO
- Analyst Count
- ORGO 3
- NDMO 0
- Target Price
- ORGO $8.00
- NDMO N/A
- AVG Volume (30 Days)
- ORGO 3.1M
- NDMO 218.6K
- Earning Date
- ORGO 11-06-2025
- NDMO 01-01-0001
- Dividend Yield
- ORGO N/A
- NDMO 6.75%
- EPS Growth
- ORGO N/A
- NDMO N/A
- EPS
- ORGO N/A
- NDMO N/A
- Revenue
- ORGO $465,218,000.00
- NDMO N/A
- Revenue This Year
- ORGO $2.51
- NDMO N/A
- Revenue Next Year
- ORGO $25.45
- NDMO N/A
- P/E Ratio
- ORGO N/A
- NDMO N/A
- Revenue Growth
- ORGO 2.24
- NDMO N/A
- 52 Week Low
- ORGO $2.61
- NDMO $8.99
- 52 Week High
- ORGO $7.08
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- ORGO 50.25
- NDMO 51.08
- Support Level
- ORGO $5.09
- NDMO $10.40
- Resistance Level
- ORGO $5.83
- NDMO $10.58
- Average True Range (ATR)
- ORGO 0.50
- NDMO 0.17
- MACD
- ORGO -0.08
- NDMO -0.02
- Stochastic Oscillator
- ORGO 3.02
- NDMO 53.51
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.